Corporate leadership turnover continues in biotech and pharma. Bristol Myers Squibb announced AstraZeneca’s Cristian Massacesi will succeed Samit Hirawat as chief medical officer on August 1, following Hirawat’s leadership marked by significant oncology and immunotherapy advancements. Llusern Scientific appointed a new CMO, CFO, and CTO, signaling growth in point-of-care diagnostics. PhenoTips named a VP of revenue. There are ongoing leadership adjustments at Thermo Fisher Scientific, Agilent Technologies, and others. Executive transitions reflect shifting priorities and strategic recalibration across life sciences sectors.